0% found this document useful (0 votes)
22 views84 pages

Pharmacotherapeutics Course Overview

Provide safe and effective pain management while minimizing risk of harm  Patient will demonstrate no adverse effects from morphine administration

Uploaded by

Jesus Martinez
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
22 views84 pages

Pharmacotherapeutics Course Overview

Provide safe and effective pain management while minimizing risk of harm  Patient will demonstrate no adverse effects from morphine administration

Uploaded by

Jesus Martinez
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

NURS 3304

PHARMACOTHERAPEUTICS

Adrianne Linton PhD RN


Jennie Shaw MSN RN
Blackboard Assistance by
MaryShannon Williams
Course
Objectives
Course Objectives
 Examine the role of drug therapy in
relation to health promotion, disease
prevention and management across the
lifespan. (Essential VII, IX)
 Incorporate understanding of drug
classifications and actions. (Essential VII,
IX)
 Identify relevant assessment data,
appropriate nursing goals and
intervention, and evaluation data related
to drug therapy. (Essential IX)
 Identify the need for customization of drug
therapy based on individual patient
variables including physiologic,
psychosocial, genetic, cultural, patient
belief system, knowledge base and
resources. (Essential VII, IX)
 Integrate knowledge of physical and
behavioral sciences with legal and ethical
guidelines to plan for safe and effective
implementation of pharmacotherapeutics.
(Essential I, II, V, IX)
 Identify strategies to employ
intraprofessional communication related to
patient’s drug therapy. (Essential VI, IX)
 Describe how the nurse prepares patients
and their families to manage self-
pharmacotherapeutics. (Essential VI, IX)
 Identify information technology sources for
the acquisition and application of
evidence-based guidelines to practice.
(Essential III. IV, IX)
 Use critical thinking process to apply
knowledge of pharmacology to plan safe
and effective drug therapy. (Essential I, IX)
Drug Calculations….

 The School of Nursing has adopted


Dimensional Analysis as the method of
performing math/drug calculations.
 It is expected that you already know basic
math and you will have an opportunity to
review this skill.
Criteria for Evaluation
 Grade Percentages:
25% - Exam 1 
25% - Exam 2 
30% - Final Exam
10% - Current Event Written Assignment
10% - Blackboard Activities and Participation
100% - Total
Textbooks
 Required
 Lehne, R. A. (2010) Pharmacology for Nursing Care
(7th ed.)
 Mulholland, Joyce M. (2007) The Nurse, The Math,
The Meds: Drug Calculations using Dimensional
Analysis
Recommended
Basch & Ulbright: Natural Standard Herb and
Supplement Handbook (2005)
Publication Manual of the American Psychological
Association (2009)
Equivalencies
 1 liter (L) = 1000 milliliters
(mL)
 1 kilogram (kg) = 1000 grams
 1 gram (g) = 1000 milligrams
(mg)
 1 milligram (mg) = 1000
micrograms (mcg)
Equivalencies
 1 tsp = 5 mL  1 gr = 60, 64, or 65
 1 Tbsp = 15 mL mg
 1 ounce = 30 mL  15 gr = 1 Gm
 1 glass = 240 mL  1 kg = 2.2 lbs
Abbreviations

cc oz IV
g, gm, Gm ss OD
gr T.O. OS
gtt Unit OU
kg V.O. PO
L, l x – (times) PR
mcg, µg < SC, subc, sc
mEq > Sl, sl
Mg, mg ID Vag
ml IM
Abbreviations
AC PC STAT
Ad lib PRN TID
c Q, q
H, h Q AM
hs, HS QID
NPO s
“Do Not Use” Abbreviations
 The Joint Commission
 [Link]
Patient Safety
Do Not Use List
National Patient Safety Goals
Pharmacology

 A science that draws on information from


multiple disciplines, including:
Anatomy
Physiology
Psychology
Chemistry
Microbiology
Basic Terms

 Drug
Any chemical that can affect living
processes
 Pharmacology
Study of drugs and their interactions
with living systems
Basic Terms

 Clinical pharmacology
Study of drugs in humans
 Therapeutics
The use of drugs to diagnose, prevent,
or treat disease or to prevent
pregnancy, or more simply: the medical
use of drugs
Conventional Drugs

 Used in Western medicine


 Production regulated
 Meet standards for safety and efficacy
 Include prescription and OTCs
Non-allopathic Agents
 Folk remedies
 Herbal supplements
 Limited evidence of safety and efficacy
(but growing)
 Promote consumer choice and self
treatment
USES OF DRUG THERAPY
Drugs modify existing functions on a tissue or
body organ
Drugs do not create new functions – important to
know this.
 Restore normal level of deficient
substances
 Block harmful physiologic processes
 Stimulate healthy physiologic processes
USES (cont.)

 Destroy pathogens
 Destroy abnormal tissue
 Protect vulnerable tissue-sunscreen ex, creams
to protect the skin
 Eliminate excess or harmful substances-
direutics,
 Reduce symptoms-ex Tylenol.
FUNDAMENTAL PRINCIPLES
All drugs are potential poisons when
taken in sufficiently high doses
No drug produces one, and only one,
effect
Orientation to Pharmacology

 Properties of an ideal drug


 The therapeutic objective
 Factors that determine the intensity of
drug responses
 Therapeutics
Three Most Important
Properties of an Ideal Drug
1. Effectiveness-does what is suppose to do
2. Safety-there is no such thing as a safe
drug
3. Selectivity-meaning that it doesn’t ONLY
what its meant to do, BUT NO SUCH
DRUG EXISTS.
Additional Properties of an Ideal Drug

 Reversible action-ex. Anethesia, morphine


 Predictability-can’t be totally predicted,
everyone is different.
 Ease of administration-ex pill, insulin by
injection,
 Freedom from drug interactions-
 Low cost-
 Chemical stability-
 Simple generic name-
But because no drug is ideal …
Therapeutic Objective of
Drug Therapy
 Provide maximum benefit with
minimum harm
Factors That Determine the Intensity of
Drug Responses
 Administration-
 Pharmacokinetics-how drugs “move”
through your body
 Pharmacodynamics-how do they work
 Sources of individual variation
Fig. 1-1. The four basic pharmacokinetic processes.
Dotted lines represent membranes that must be crossed as drugs move throughout the body.
Administration

 Important determinants of drug responses:


dosage size, route, timing
 Medication errors
 Patient adherence
Pharmacokinetics

 Determining how much of administered


dose gets to its sites of action
 Impact of the body on drugs
 Four major pharmacokinetic processes:
Drug absorption
Drug distribution
Drug metabolism
Drug excretion
Pharmacodynamics

 Impact of drugs on the body


 Drug-receptor interaction
Binding of the drug to its receptor
Sources of Individual Variation

 Physiologic variables
Age, gender, weight
 Pathologic variables
Diminished function of kidneys and liver
 Genetic variables
Can alter metabolism of drugs and predispose
patient to unique interactions
 Drug interactions
Key Points

 There is no such thing as a safe drug; all


drugs can cause harm.
 There is no such thing as a selective drug;
all drugs can cause side effects.
 The objective of drug therapy is to provide
maximum benefit with minimum harm.
 Because all patients are unique, drug
therapy must be tailored to each
individual.
Chapter 2

Application of Pharmacology in
Nursing Practice
Nursing Responsibilities Regarding Drugs

 The nurse must know…


What medications are appropriate for
the patient
What drugs are contraindicated for the
patient
The probable consequences of the
interaction between drug and patient
Nursing Responsibilities Regarding Drugs

 Correct administration, without


additional interventions, cannot ensure
that treatment will result in the
therapeutic objective.-
 Therapeutic objective is to provide

maximum benefit with minimal harm.


Nursing Responsibilities Regarding Drugs

 The nurse’s role as advocate


Follows the patient’s status most closely
First member of the health care team to
observe and evaluate drug responses and
intervene if required
Must know the response that a medication is
likely to elicit
Last line of defense for the patient-last person
the patient can count on
Pharmacology in Patient Care

Nurse responsibility and


accountability

 Patient has a cardiac arrest after receiving a


rapid infusion of potassium.-
Nurse Responsibility and Accountability
 Pregnant woman has
a preservative instead  NICU babies die
of an anesthetic drug after overdose of
injected into her heparin.
spinal column. She is
totally paralyzed and
dies several months
later.
As a nurse you are responsible for
every drug that you administer.
The Nursing Process guides the
nurse in administering drugs safely.
The Nursing Process

Assessment
Nursing Diagnosis
Planning/Goals
Interventions
Evaluation
Assessment: Patient- this always
happens FIRST

 Current status-level of conscious


 Past (health) history
Medication history
Allergies
Assessment: Patient

 Identifying high-risk patients


Liver and kidney impairment
Genetic factors
Drug allergies
Pregnancy
Elderly and pediatrics
Tools: patient history, physical exam,
and lab results
Assessment: Drug
Complete, legal order
Appropriateness (rationale for use of
this drug for this patient)
Action, dosage, route, adverse effects
Contraindications, interactions
Other data: lab results, vital signs, etc
Assessment: Delivery system
 Drug administration and security
 Drug handling
 Dosage measuring
 Obtaining the drug
 Systems used to dispense the drug
 How to document drug therapy on the
MAR (medication administration record)
Nursing Diagnoses
 Acute pain related to tissue
trauma and reflex muscle spasms
secondary to surgery as evidenced
by grimacing, reluctance to get out
of bed, and a pain score of 8.
 Risk for injury related to sedating
effects of opioid analgesics
Planning/Setting Goals
 Patient will have pain level of 3 or less
within 30 minutes of administration of
morphine
 Patient will remain safe after pain
medication is administered as
evidenced by no falls or injuries today
Interventions:
Drug Administration
 Six rights
 Is this enough to
Patient – 2 identifiers!
meet the
Drug therapeutic
Dose objective?
Route
Time
Right documentation
…right to refuse
Interventions:
Drug Administration
 Keep medication secure-
 Be knowledgeable about institution’s
policies and procedures
 Never administer medication prepared by
another nurse-
 Nurse must observe patient taking
medication-
Interventions:
Drug Administration
 Certain drugs have more than one
indication. Dosage may differ depending
on which indication the drug is used for.
 Many drugs can be administered by more
than one route. Dosage may differ
depending on the route selected.
 Certain IV agents can cause severe local
injury if IV extravasates.
Interventions:
Documentation
 When to chart-do it immediately after you give meds.
 Where to chart-
 What to chart
Why given or not (PRN vs routine)
Effects
Other relevant data
Military time……
Interventions:
Teaching

Considerations
Knowledge
Readiness to
learn
Environment
Teaching May Include…
 Drug  Effects of suddenly
 Schedule discontinuing
 Therapeutic effects  What if dose
 Adverse effects missed
 Interactions  Safety
considerations
 Handling/storage
Evaluation
Of Drug Effects
 Therapeutic response
 Adverse effect (includes side effects)
 Interactive effects
 Further teaching needs
Promoting Therapeutic Effects

 Promoting patient adherence


Also known as compliance or concordance
Extent to which a patient’s behavior coincides
with medical advice
 Implementing nondrug measures
Drug therapy can often be enhanced by
nondrug measures.
Biofeedback, emotional support, weight
reduction, smoking cessation, sodium
restriction, etc.
Minimizing Adverse Effects

 All drugs have the potential to produce


undesired effects.
 Always know the following:
The major adverse effects the drug can produce
The time when these reactions are likely to occur
Early signs that an adverse reaction is developing
Interventions that can minimize discomfort and
harm
Minimizing Adverse Interactions

 Take a thorough drug history.


 Advise the patient to avoid OTC drugs that
can interact with the prescribed
medication.
 Monitor for adverse interactions known to
occur.
 Be alert for as-yet unknown interactions.
Making PRN Decisions

 PRN – pro re nata, meaning “as needed”


 Know the reason for drug use.
 Be able to assess the patient’s medication
needs.
Managing Toxicity

 Early identification makes early


intervention possible.
 Know the early signs of toxicity.
 Know the procedure for toxicity
management.
Chapter 3

Drug Regulation, Development,


Names, and Information
Overview of Chapter 3

 Landmark drug legislation


 New drug development
 Drug names
 Over-the-counter drugs
 Sources of drug information
Landmark Drug Legislation

 Federal Pure Food and Drug Act, 1906


  Food, Drug, and Cosmetic Act, 1938
  Harris-Kefauver Amendments, 1962
 Controlled Substances Act, 1970
Food Drug and Cosmetic Act (1938)
 Targeted safety and efficacy
 Regulated manufacture, distribution,
advertising, labeling
 Made USP official standard for strength
and purity
 [Link]
Food Drug and Cosmetic Act (1938)

 Designated FDA to enforce


 Role of the FDA
 [Link]
Harris Kefauver Amendment

 First law to demand that drugs actually


offer some benefit
Comprehensive Drug Abuse
Prevention and Control Act (1970)

 Classified and regulated drugs with


potential for abuse
 Established drug abuse education and
treatment programs
Really focus on this ACT ***
 Schedule 1: high abuse potential, no
approved medical use
 Schedule 2: high abuse potential, accepted
medical use-codeine, anabolic steroids
 Schedule 3: less abuse potential, accepted
medical use
 Schedule 4: some abuse potential,
accepted medical use
 Schedule 5: less abuse potential than
schedule 4, accepted medical use
 Good idea to know these schedules ***
 1992 Rx Drug User Fee Act
Shortened review process
 1997 FDA Modernization Act
Permitted drug companies to provide
information about non-FDA approved uses
( off-label uses)-you CANT market a drug for a USE
that is not approved by the FDA. You can share the
information, that’s all.
New Drug Development

 The randomized controlled trial


Control use
Randomization
Blinding
Stages of New Drug Development
 Preclinical testing
 Clinical testing
Phase 1: healthy subjects
Phase 2: target group
Phase 3: larger target group
Phase 4: FDA evaluation and
postmarketing surveillance
***Know these steps. *** usually an 8 year process.
Limitations of the Testing Procedure

 Limited information for women and


children
Women
Children
 Failure to detect all adverse effects
Exercising Discretion Regarding
New Drugs
 Be neither the first to adopt the new nor
the last to abandon the old.
 Balance potential benefits against inherent
risks.
 New drugs generally present greater risks
than the old ones.
Drug Names
Which Name to Use—
Generic or Trade?
 The little problems with generic names
More complicated than trade names
 The big problems with trade names
Single drug can have multiple trade names.
U.S. drugs and drugs outside the U.S. may
have different active ingredients.
Products with the same trade name may have
different active ingredients.
 Monistat and Kaopectate
Which Name to Use—
Generic or Trade?
 Generic products versus brand-name
products
Are generic products and brand-name products
therapeutically equivalent?
Would a difference between brand-name and
generic products justify the use of trade
names?
Over-the-Counter Drugs

 Americans spend about $20 billion


annually on OTC drugs.
 OTC drugs account for 60% of all doses
administered.
 40% of Americans take at least one OTC
drug every 2 days.
 Four times as many illnesses are treated
by a consumer using an OTC drug as by a
consumer visiting a physician.
Over-the-Counter Drugs

 With most illnesses (60% to 95%), initial


therapy consists of self-care, including
self-medication with an OTC drug.
 The average home medicine cabinet
contains 24 OTC preparations.
Sources of Drug Information

 People
Clinicians and pharmacists
Poison control centers
Pharmaceutical sales representatives
Published Information

 Text-like books
Goodman & Gilman’s, The Pharmacological
Basis of Therapeutics
Pharmacotherapy: A Pathophysiologic
Approach
Applied Therapeutics: The Clinical Use of
Drugs
Published Information

 Newsletters
The Medical Letter on Drugs and Therapeutics
Prescriber’s Letter
 Reference books
Physicians’ Desk Reference
Drug Facts and Comparisons
Nursing drug references
Internet sources:
[Link]/cder/drug
[Link]-you can use this for the current event
article.

[Link]
Programs for smart phones, PDA, etc

You might also like